PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2092674
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2092674
Closed System Transfer Devices Market size was valued at US$ 1,809.02 Million in 2025, expanding at a CAGR of 15.2% from 2026 to 2033.
Closed System Transfer Devices (CSTDs) are advanced medical tools that are engineered to ensure the containment of hazardous vapor, aerosol, or liquid form of drug leakage from the system and protect it from any environmental contaminant contamination in the process of handling hazardous drugs. CSTDs work on the principle of creating a seal and ensuring a leak-proof connection between the drug container, syringe, IV line, and infusion pump to prevent occupational exposure to the hazardous drugs.
Closed System Transfer Devices Market- Market Dynamics
Growing awareness of healthcare worker safety drives the market growth
The growing importance of healthcare worker safety plays a key role in stimulating the market growth in CSTDs. Healthcare professionals like pharmacists, nurses, pharmacy technicians, oncology staff and others are frequently exposed to dangerous medications during preparation of the medicines, transferring of the hazardous drugs, administration and finally when disposing the chemicals. It has been reported that the exposure to anti-neoplastic drugs and other hazardous pharmaceuticals via the mechanism of aerosolization, vaporization, spills, accidental leaking and others has been connected with various adverse health impacts like skin lesions, reproductive toxicities, infertility, birth defects, organ damages and also increased incidence of cancer types. With increasing awareness about the occupational dangers, there has been an effort made by healthcare institutions to introduce CSTDs in order to ensure a safer working environment for their workers.
There have been issued some regulatory and organizational recommendations regarding handling of hazardous drugs and this factor also stimulates the usage of CSTDs on the market. USP <800>, NIOSH recommendations and OSHA guidelines for workplace safety require the implementation of engineering controls, which include CSTDs among others, in order to decrease exposure. The hospitals, cancer clinics and also compounding pharmacies implement CSTDs into the procedures.
The Global Closed System Transfer Devices Market is segmented on the basis of System, Closing Mechanism, Component, Technology, End User, and region.
The market is divided into two categories based on system: Needle-less Systems and Membrane-to-Membrane Systems. The Needle-less Systems segment dominates the market. This growth results from the growing attention to safety of the healthcare staff, reduction in the risk of needlesticks, and compliance with the handling regulations for hazardous drugs. The Needle-less CSTD system does not involve the usage of the traditional needles when preparing and transferring the drug, using mechanical seals of connectors, valves, and membranes for access. This system reduces the likelihood of needlesticks, and at the same time prevents the release of the harmful vapors and aerosols of hazardous drugs, thus improving the safety of pharmacists and nurses.
The market is divided into three categories based on technology: Compartmentalized Devices, Air-Filtration Devices and Diaphragm-based Devices. The Diaphragm-based Devices segment is growing at a substantial rate. Growth in this sector is attributed to their effectiveness in ensuring containment of the hazardous drugs, while at the same time ensuring that there is an aseptic pathway for the drug transfer process. This technology uses elastomer or polymeric diaphragms that act as mechanical seals that help in sealing the drug transfer path while connecting or disconnecting the device, which ensures that no hazardous drug aerosols, vapor, or liquid particles are released and contamination from the environment is prevented.
Closed System Transfer Devices Market- Geographical Insights
North America dominates the market. The development is due to the high prevalence rate of cancer, increased procedures for chemotherapy, strict guidelines for hazardous drug handling, and strong health care facilities in the area. CSTDs have been widely used in hospitals, oncology clinics, infusion centers, and compounding pharmacies in the region to help healthcare professionals avoid the occupational risk of hazardous drugs and adhere to the existing safety regulations. For example, according to the estimates of the American Cancer Society (ACS), there will be around 2.04 million new cases and 618,120 cancer-related deaths in 2025 in the United States. With the growing number of patients who undergo intravenous chemotherapy and other hazardous drugs therapy, healthcare institutions use CSTDs to minimize the risk of their occupational exposure.
US Closed System Transfer Devices Market- Country Insights
The US holds a prominent market share. With more usage of biological agents, cancer therapeutics, monoclonal antibodies, and other such dangerous injectables, there will be an expansion in the market. Moreover, the growing trend of outpatients undergoing chemotherapy and using ambulatory infusion centers has led to an increased need for safe and easy drug transfer devices. Technological developments include needle-free connectors, diaphragm containment technology, vapor containment technology, and compatibility with various drug delivery devices.
In the market for Closed System Transfer Devices (CSTDs), there is the existence of a number of leading medical device companies across the globe that compete among themselves on the basis of innovation, compliance with regulations, strategic alliances, and portfolio extension. The competitive environment in the market is being created due to growing requirement for safer solutions of hazardous drug handling from hospitals, oncology departments, ambulatory infusion centers, and compounding pharmacies. Participants in the market are working to develop CSTDs with improved vapor retention, sealing mechanisms, needle-free connections, ergonomics, and compatibility with various syringes, vials, and IV set up devices.
In May 2025, EQUASHIELD(R), a global leader in Closed System Transfer Devices (CSTDs) and automated compounding solutions, proudly announced that it has been ranked as the #1 CSTD used in US pharmacies for the seventh consecutive year by Pharmacy Purchasing & Products. This milestone highlights EQUASHIELD(R)'s commitment to innovation, safety, and efficiency in protecting healthcare workers from hazardous drug exposure.
In December 2024, Zephyrus Innovations (Zephyrus), a privately-owned medical device company designing and manufacturing safety syringes and Closed System Transfer Devices (CSTDs), announced its latest product, VaporShield, the world's first injectable closed system transfer device (CSTD), at the Partnership Opportunities in Drug Delivery (PODD) conference in Boston, MA last month.